KOC
CLB icon

Koss-Olinger Consulting’s Core Laboratories CLB Stock Holding History

Koss-Olinger Consulting’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-13,087
Closed -$266K – 277
2024
Q2 		$266K Buy
+13,087
New +$232K 0.02% 224

Other funds holding CLB

AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Koss-Olinger Consulting's CLB Position: Q3 2024 in Review

Koss-Olinger Consulting sold out of Core Laboratories (CLB) in Q3 2024, closing a stake of 13,087 shares — an estimated $266K sold.

Koss-Olinger Consulting first reported a position in CLB in Q2 2024 and held it in 1 quarter. The position peaked at $266K in Q2 2024. 191 funds tracked by Wall St. Rank hold CLB as of Q3 2024.

  • Koss-Olinger Consulting reported no remaining Core Laboratories position as of Q3 2024 after selling out during the quarter.
  • Koss-Olinger Consulting sold 13,087 Core Laboratories shares in Q3 2024, an estimated $266K.
  • Koss-Olinger Consulting first reported a position in Core Laboratories in Q2 2024 and held it in 1 quarter.
  • Koss-Olinger Consulting's Core Laboratories position peaked at $266K in Q2 2024.
  • 191 funds tracked by Wall St. Rank held Core Laboratories as of Q3 2024.

Based on Koss-Olinger Consulting's 13F filing for Q3 2024, filed 21 Oct 2024.